Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Cancer Vaccines Market Snapshot (2023 to 2033)

The global Cancer Vaccines Market is expected to garner a market value of US$ 9 Billion in 2023 and is expected to accumulate a market value of US$ 24.22 Billion by registering a CAGR of 12% in the forecast period 2023 to 2033. The market for Cancer Vaccines registered a CAGR of 9% in the historical period 2018 to 2022.

The Cancer Vaccines market is a segment of the healthcare industry that deals with the effective management of the condition. The Cancer Vaccines market offers a range of vaccines that uses the body's own immune system to recognize and attack cancer cells. There are two main types of cancer vaccines: preventive vaccines and therapeutic vaccines. Preventive vaccines are designed to prevent certain types of cancer, such as the HPV vaccine that helps prevent cervical cancer. Therapeutic vaccines, on the other hand, are designed to treat cancer by stimulating the immune system to recognize and attack cancer cells.

Report Attribute Details
Expected Market Value (2023) US$ 9 Billion
Anticipated Forecast Value (2033) US$ 24.22 Billion
Projected Growth Rate (2023 to 2033) 12% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Cancer Vaccines Market Demand Analysis vs. Forecast 2023 to 2033

According to market research and competitive intelligence provider, Future Market Insights- the market for Cancer Vaccines reflected a value of 9% during the historical period, 2018 to 2022. During this period, the demand for treatment for Cancer increased, driven by factors such as increasing incidence of cancer, growing awareness about cancer prevention and treatment, and technological advancements in vaccine development.

Looking ahead to the period from 2023 to 2033, the cancer vaccines market is expected to continue growing, although at a slightly slower pace than in the previous period. Cancer is expected to remain a major health concern globally, which will drive demand for cancer vaccines. In recent years, several new cancer vaccine options have emerged for Cancer, pushing the market for Cancer Vaccines is expected to register a CAGR of 12% in the forecast period 2023 to 2033.

Which are Some Prominent Drivers of the Cancer Vaccines Market?

Growing advancements in diagnostic and treatment options to push the market growth

The Cancer Vaccines Market is expected to experience significant growth in the coming years, driven by several factors. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, responsible for an estimated 9.6 million deaths in 2018. The most common types of cancer worldwide include lung, breast, colorectal, prostate, stomach, and liver cancer.

The increasing prevalence of cancer has led to the development of new technologies such as gene editing and personalized medicine is enabling the development of more effective cancer vaccines. The prevalence of cancer varies by region and demographic group. Low- and middle-income countries are disproportionately affected by cancer, with over 60% of new cancer cases and 70% of cancer deaths occurring in these countries. This is due to a combination of factors including lack of access to prevention and early detection services, limited resources for cancer vaccine, and higher rates of risk factors such as tobacco use and infectious diseases.

Cancer is a major public health concern globally, with millions of new cases diagnosed each year. Overall, the prevalence of cancer is expected to continue to increase globally, with an estimated 29.5 million new cancer cases and 16.5 million cancer deaths expected by 2040, according to the International Agency for Research on Cancer (IARC). The combination of these factors is expected to drive significant growth in the Cancer vaccines market in the coming years.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Cancer Vaccines Market?

Expensive Cost of Treatment to restrict Market Growth

Cancer is a complex disease, and its nature differs from person to person. As a result, developing a vaccine that can effectively treat all forms of cancer is a major challenge. The current cancer vaccines on the market have limited success rates, and there is a need to develop more effective vaccines to meet the growing demand for cancer treatment.

Many people are not aware of the benefits of cancer vaccines, and this can limit their adoption and use. Furthermore, regulatory challenges can limit the development and approval of new vaccines for Cancer, which can slow down progress in the field. Some people may be resistant to vaccines, and this can limit the effectiveness of cancer vaccines.

Region-Wise Insights

How is the Cancer Vaccines Market Turning Out in the South & East Asia Region?

Increasing Advancements in the Diagnostic Techniques Shaping Landscape for Cancer Vaccines in South & East Asia

The Cancer Vaccines Market in the South and East Asia region is growing, driven by several factors such as increasing cancer incidence, growing awareness about cancer prevention, and the rising demand for personalized medicine are driving the growth of the cancer vaccine market in the region. Additionally, the increasing adoption of advanced technologies such as Next-generation sequencing (NGS) and bioinformatics in cancer research is expected to further fuel market growth.

In South and East Asia, the Cancer Vaccines Market is expected to witness significant growth in the coming years, driven by factors such as increasing cancer incidence, growing demand for innovative treatment options, and rising investments in cancer research and development.

In addition, there is a growing awareness about the disease in the region, which is leading to more frequent diagnoses and better access to vaccines. Governments and healthcare organizations are also taking steps to improve the diagnosis and treatment of Cancer, which is helping to drive growth in the market.

What are the Factors Boosting the Market for Cancer Vaccines in North America?

Increasing Focus on Technological advancements Shaping Landscape for Cancer Vaccines in North America

North America is anticipated to acquire a market share of about 40% in the forecast period. As awareness about cancer vaccines increases among the general population, more people are opting for these vaccines as a preventive measure against cancer. North America has some of the world's leading research institutions, which are dedicated to developing new and effective cancer vaccines. This has led to the development of several innovative cancer vaccines in recent years.

Additionally, The regulatory environment for cancer vaccines in North America is favorable, with regulatory agencies such as the FDA in the USA providing fast-track approval for promising cancer vaccines. Healthcare expenditure in the region is increasing, which has led to increased investment in cancer treatment and prevention, including cancer vaccines.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

By Technology, Which Segment is Likely to Account for a Significant Share?

Recombinant cancer vaccines segment to hold a significant share and push market growth

Currently, the recombinant cancer vaccines segment is expected to account for a significant share of the market. Recombinant cancer vaccines are developed using genetic engineering technology, which enables the production of specific proteins that can stimulate the immune system to attack cancer cells. This technology has shown promising results in clinical trials and has been approved for use in the treatment of certain types of cancer, such as prostate cancer and melanoma.

By Treatment, Which Segment is Likely to Account for a Significant Share?

Therapeutic cancer vaccines to take the lead and drive market growth

Currently, the therapeutic cancer vaccines segment is expected to account for a significant share of the market. Therapeutic cancer vaccines are designed to stimulate the immune system to attack existing cancer cells in patients who have already been diagnosed with cancer. These vaccines are being developed for a variety of cancer types and have shown promising results in clinical trials.

Market Competition

Key players in the market include companies such as Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and OSE Immunotherapeutics, along with healthcare providers and technology companies among other global players.

  • In January 2023, the United kingdom government announced a collaboration with BioNTech, a German company, to trial potential vaccines for cancer and other illnesses, while campaigners cautioned that any breakthrough must remain affordable and accessible. Personalized mRNA therapies, including cancer vaccines that aim to activate the immune system against harmful cells, will be tested on cancer patients in England at both early and late stages. The therapies target active cancer cells and work to prevent their return. BioNTech will establish new research and development centers in the United kingdom, including a laboratory in Cambridge and a headquarters in London, and aim to supply 10,000 therapies to patients from September 2023 until the end of the decade.

The firm developed one of the most widely-distributed Covid-19 vaccines in collaboration with USA pharmaceutical firm Pfizer. The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.

Report Scope

Report Attribute Details
Market Value in 2023 US$ 9 Billion
Market Value in 2033 US$ 24.22 Billion
Growth Rate CAGR of 12% from 2023 to 2033
Base Year for Estimation 2022
Historical Data 2018 to 2022
Forecast Period 2023 to 2033
Quantitative Units Revenue in USD Million and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
  • Technology
  • Treatment Method
  • Application
  • Region
Regions Covered
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Mexico
  • Rest of Latin America
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Malaysia
  • Singapore
  • China
  • India
  • Thailand
  • Rest of South Asia
  • Gulf Cooperation Council
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • GCC countries
  • South Africa
  • Israel
  • Rest of MEA
Key Companies Profiled Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and OSE Immunotherapeutics
Customization Available Upon Request

Key Segments Profiled in the Cancer Vaccines Industry Survey

Technology:

  • Recombinant Cancer Vaccines
  • Whole-cell Cancer Vaccines
  • Viral Vector & DNA Cancer Vaccines
  • Antigen/Adjuvant Cancer Vaccines

Treatment Method:

  • Preventive Vaccine
  • Therapeutic Vaccine

Application:

  • Prostate Cancer
  • Cervical Cancer
  • Other Applications

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Frequently Asked Questions

At what rate did the Cancer Vaccines Market flourish from 2018 to 2022?

From 2018 to 2022, the Cancer Vaccines Market grew at a CAGR of 9%.

What will be the growth rate of the global Cancer Vaccines Market during the forecast period?

The global Cancer Vaccines Market is expected to grow with a 12% CAGR during 2023 to 2033.

What will be the projected market size of the Cancer Vaccines Market by 2033?

As of 2033, the Cancer Vaccines Market is expected to reach US$ 24.22 Billion

Which technology is expected to dominate the global Cancer Vaccines Market during 2033?

According to the FMI analysis, the recombinant cancer vaccines segment accounts for the largest market share.

How is the North America Cancer Vaccines Market projected to grow in 2033?

North America is expected to possess 40% market share for the Cancer Vaccines Market.

How is the Asia Pacific Cancer Vaccines Market projected to grow in 2033?

The Asia Pacific market is projected to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

What is the Expected CAGR from 2023 to 2033?

The market is expected to record a 12% CAGR throughout 2033.

Which Factors will Expand the Market?

Innovations in diagnostics and treatment options are likely to grow the market.

Which Technology type is Estimated to Dominate the Market?

Recombinant cancer vaccines to dominate the market.

What is the Expected Market share of North America in 2033?

North America to acquire a 40% share during the forecast period. 

What is the Global Market Projected Value for 2033?

The market is expected to accumulate a value of US$ 24.22 billion by 2033.

Table of Content

1. Executive Summary | Cancer Vaccines Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033

        5.3.1. Recombinant Cancer Vaccines

        5.3.2. Whole-cell Cancer Vaccines

        5.3.3. Viral Vector & DNA Cancer Vaccines

        5.3.4. Antigen/Adjuvant Cancer Vaccines

    5.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Method

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Method, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Method, 2023 to 2033

        6.3.1. Preventive Vaccine

        6.3.2. Therapeutic Vaccine

    6.4. Y-o-Y Growth Trend Analysis By Treatment Method, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Treatment Method, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033

        7.3.1. Prostate Cancer

        7.3.2. Cervical Cancer

        7.3.3. Other Applications

    7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Technology

        9.2.3. By Treatment Method

        9.2.4. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Technology

        9.3.3. By Treatment Method

        9.3.4. By Application

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Technology

        10.2.3. By Treatment Method

        10.2.4. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Technology

        10.3.3. By Treatment Method

        10.3.4. By Application

    10.4. Key Takeaways

11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. United kingdom

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Technology

        11.2.3. By Treatment Method

        11.2.4. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Technology

        11.3.3. By Treatment Method

        11.3.4. By Application

    11.4. Key Takeaways

12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Technology

        12.2.3. By Treatment Method

        12.2.4. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Technology

        12.3.3. By Treatment Method

        12.3.4. By Application

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Technology

        13.2.3. By Treatment Method

        13.2.4. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Technology

        13.3.3. By Treatment Method

        13.3.4. By Application

    13.4. Key Takeaways

14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Technology

        14.2.3. By Treatment Method

        14.2.4. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Technology

        14.3.3. By Treatment Method

        14.3.4. By Application

    14.4. Key Takeaways

15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Technology

        15.2.3. By Treatment Method

        15.2.4. By Application

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Technology

        15.3.3. By Treatment Method

        15.3.4. By Application

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Technology

            16.1.2.2. By Treatment Method

            16.1.2.3. By Application

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Technology

            16.2.2.2. By Treatment Method

            16.2.2.3. By Application

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Technology

            16.3.2.2. By Treatment Method

            16.3.2.3. By Application

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Technology

            16.4.2.2. By Treatment Method

            16.4.2.3. By Application

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Technology

            16.5.2.2. By Treatment Method

            16.5.2.3. By Application

    16.6. United kingdom

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Technology

            16.6.2.2. By Treatment Method

            16.6.2.3. By Application

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Technology

            16.7.2.2. By Treatment Method

            16.7.2.3. By Application

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Technology

            16.8.2.2. By Treatment Method

            16.8.2.3. By Application

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Technology

            16.9.2.2. By Treatment Method

            16.9.2.3. By Application

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Technology

            16.10.2.2. By Treatment Method

            16.10.2.3. By Application

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Technology

            16.11.2.2. By Treatment Method

            16.11.2.3. By Application

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Technology

            16.12.2.2. By Treatment Method

            16.12.2.3. By Application

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Technology

            16.13.2.2. By Treatment Method

            16.13.2.3. By Application

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Technology

            16.14.2.2. By Treatment Method

            16.14.2.3. By Application

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Technology

            16.15.2.2. By Treatment Method

            16.15.2.3. By Application

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Technology

            16.16.2.2. By Treatment Method

            16.16.2.3. By Application

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Technology

            16.17.2.2. By Treatment Method

            16.17.2.3. By Application

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Technology

            16.18.2.2. By Treatment Method

            16.18.2.3. By Application

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Technology

            16.19.2.2. By Treatment Method

            16.19.2.3. By Application

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Technology

            16.20.2.2. By Treatment Method

            16.20.2.3. By Application

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Technology

            16.21.2.2. By Treatment Method

            16.21.2.3. By Application

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Technology

        17.3.3. By Treatment Method

        17.3.4. By Application

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Advaxis Inc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Amgen Inc.

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Dynavax Technologies Corporation

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Generex Biotechnology Corporation

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. GlaxoSmithKline plc

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Immunocellular Therapeutics, Ltd

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. Merck & Co., Inc.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Vaccinogen, Inc.

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. F Hoffmann-La Roche AG

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. OSE Immunotherapeutics

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Cancer Biological Therapy Market

Published : December 2022

Healthcare

Cancer Supportive Care Products Market

Published : July 2020

Explore Healthcare Insights

View Reports